Pharmaceutical Technology Editorial Advisory Board
Pharmaceutical Technology North America and Pharmaceutical Technology Europe magazines publish contributed technical articles that undergo a double-blind peer-review process involving members of our distinguished Editorial Advisory Boards (EAB). The EAB are specialists representing various facets of the pharmaceutical industry. EAB members review manuscripts, recommend subject matter and answer questions when they arise.
- Larry L. Augsburger, PhD, Professor Emeritus, University of Maryland School of Pharmacy
- Reinhard Baumfalk, Vice President Global Engineering Factory Automation, Emerson Automation Solutions
- Phil Borman, DSc, CChem, FRSC, Senior Director QbD & Digital Platform Portfolio & Technology Delivery, Medicine Development & Supply, Pharma R&D, GSK
- Evonne Brennan, Consultant at Evonne Brennan Consulting
- Rory Budihandojo, Independent GMP Consultant
- Christopher Burgess, Managing Director, Burgess Analytical Consultancy
- Metin Çelik, PhD, President, Pharmaceutical Technologies International (PTI)
- Robert Dream, Managing Director, HDR Company
- Sanjay Garg, PhD, Professor and Director, Centre for Pharmaceutical
Innovation and Development, University of South Australia - Filipe Gaspar, Vice-President Technology Intensification
Hovione - Ruey-ching (Richard) Hwang, PhD, Executive Director, Clinical Supply Operations, Pfizer Global R&D
- Henrik Johanning, CEO, Senior Consultant, Genau & More A/S
- Mansoor A. Khan, PhD, Regents Professor and Vice Dean, Presidential Impact Fellow, Rangel College of Pharmacy, Texas A&M University
- Heidi M. Mansour, PhD, Professor, Center for Translational Science, FIU Center for Translational Science
- R. Christian Moreton, PhD, Partner, FinnBrit Consulting
- Fernando J. Muzzio, PhD, Distinguished Professor, Chemical and Biochemical, Engineering Rutgers University
- Christa Myers, Senior Fellow–Aseptic & Sterile Products, CRB
- Moheb M. Nasr, PhD, Principal, Nasr Pharma Regulatory Consulting
- Siegfried Schmitt, PhD, Vice‑President Technical, PAREXEL International
- Susan. J. Schniepp, Distinguished Fellow, Regulatory Compliance Associates. Click HERE for a spotlight on Sue Schniepp.
- David R. Schoneker, President, Black Diamond Regulatory Consulting
- Aloka Srinivasan, Principal and Managing Partner, RAAHA LLC
- Griet Van Vaerenbergh, Marketing Manager Pharma Solid Dosage, GEA Process Engineering
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Prokaryotics Licenses Gram-Negative Antibiotic Potentiator from Northern Antibiotics
June 26th 2025Prokaryotics will gain worldwide rights to develop, manufacture, and commercialize NAB741, a non-bioactive polymyxin designed to increase permeability of the outer membrane of Gram-negative bacteria.
